Emerald Health Therapeutics Inc (OTCMKTS:EMHTF) has launched ultra pure sync 25 CBD oil to fill the recreational space in British Columbia. It is a smoke-free and non-THC alternative to the consumers.
Emerald has sent 6,000 40 ml units of Sync 25 CBD oil to BCLDB (British Columbia Liquor Distribution Branch). Executive Chairman and President of Emerald, Dr. Avtar Dhillon said the company is pleased to introduce wellness product SYNC 25 under its brand to fill the gap in the recreational market of British Columbia.
Extraction of SYNC 25 CBD oil
The new product launch is part of Emerald’s growth strategy, and to enjoy higher profit margins through developing quality and innovative products. Medipharm Labs Inc extracts the SYNC 25 CBD oil for Emerald.
CEO of Medipharm, Pat McCutcheon said the company’s expertise in extracting the SYNC 25 CBD oil complements the success of Emerald to introduce the product to meet the growing demand. The company will strive to supply high-quality cannabis concentrates on supporting the expansion plans of Emerald. SYNC 25 CBD oil is available online for immediate purchase.
Appointment of Chief Operating Officer
Emerald has posted Sean Rathbone as COO. He will contribute expertise in technology advancement, corporate process management, operational leadership, raw materials refinement, and waste reduction.
Executive Chairman said Rathbone is an industrial engineer and brings experience in promoting the growth of operational mandate on a large scale. Rathbone will play a vital role in introducing technologies, processes, and policies to achieve the production targets as Emerald continues on an expansion spree to satisfy the growing demand for cannabis products in Canada. He will ensure operational efficiencies and maintain performance standards companywide.
Rathbone has played the role of Vice President (Production), Western Canada at Agropur. He also worked as a Manager (Manufacturing R&D) BDO Canada LLP.
Standard processing license
Health Canada has awarded standard processing license to Pure Sunfarms for 1.1 million sq. Ft Delta 3 Greenhouse facility. The license allows Pure Sunfarms the extraction and processing of cannabis at Delta 3 Greenhouse facility. Emerald holds a stake of 50% in the joint venture: Pure Sunfarms, which requires an amended sales license to market cannabis oil.
UFC has signed a multi-million dollar, multi-year exclusive global partnership accord with Aurora Cannabis…
Canopy Growth Corp (NYSE:CGC)’s planned takeover provides an immediate and significant advantage in…
Medipharm Labs Corp (OTCMKTS:MEDIF) has entered a supply accord with Cronos Group Inc (NASDAQ:CRON) to…
7ACRES, a subsidiary of Supreme Cannabis Inc (OTCMKTS:SPRWF), has received the approval of Health Canada…
Published at Wed, 29 May 2019 12:01:33 +0000